200 related articles for article (PubMed ID: 7459369)
1. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Turcotte JG; Srivastava SP; Steim JM; Calabresi P; Tibbetts LM; Chu MY
Biochim Biophys Acta; 1980 Sep; 619(3):619-31. PubMed ID: 7459369
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic liponucleotide analogs. I. Chemical synthesis of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
Turcotte JG; Srivastava SP; Meresak WA; Rizkalla BA; Louzon F; Wunz TP
Biochim Biophys Acta; 1980 Sep; 619(3):604-18. PubMed ID: 7459368
[TBL] [Abstract][Full Text] [Related]
3. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid derivatives of nucleoside analogs as prodrugs with enhanced catabolic stability.
Matsushita T; Ryu EK; Hong CI; MacCoss M
Cancer Res; 1981 Jul; 41(7):2707-13. PubMed ID: 7248939
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE
J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet phosphatidylinositol synthetase by an analog of CDP-diacylglycerol.
Vargas LA; Li XM; Rosenthal AF
Biochim Biophys Acta; 1984 Nov; 796(2):123-8. PubMed ID: 6093888
[TBL] [Abstract][Full Text] [Related]
7. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
Hong CI; Bernacki RJ; Hui SW; Rustum Y; West CR
Cancer Res; 1990 Jul; 50(14):4401-6. PubMed ID: 2364392
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a novel nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors.
Tanaka M; Matsuda A; Terao T; Sasaki T
Cancer Lett; 1992 May; 64(1):67-74. PubMed ID: 1596880
[TBL] [Abstract][Full Text] [Related]
9. A phospholipid derivative of cytosine arabinoside and its conversion to phosphatidylinositol by animal tissue.
Raetz CR; Chu MY; Srivastava S; Turcotte JG
Science; 1977 Apr; 196(4287):303-5. PubMed ID: 191910
[TBL] [Abstract][Full Text] [Related]
10. 1-beta-D-Arabinofuranosylcytosine-5'-alkylphosphonophosphates and diphosphates: new orally active derivatives of ara-C.
Brachwitz H; Bergmann J; Fichtner I; Thomas Y; Vollgraf C; Langen P; Berdel WE
J Lipid Res; 1998 Jan; 39(1):162-72. PubMed ID: 9469595
[TBL] [Abstract][Full Text] [Related]
11. 1-beta-D-arabinofuranosylcytosine-diphosphate-choline is formed by the reversal of cholinephosphotransferase and not via cytidylyltransferase.
Kucera GL; Capizzi RL
Cancer Res; 1992 Jul; 52(14):3886-91. PubMed ID: 1377599
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
[TBL] [Abstract][Full Text] [Related]
14. Phospholipid-nucleoside conjugates. 3. Syntheses and preliminary biological evaluation of 1-beta-D-arabinofuranosylcytosine 5'-monophosphate-L-1,2-dipalmitin and selected 1-beta-D-arabinofuranosylcytosine 5-diphosphate-L-1,2-diacylglycerols.
Ryu EK; Ross RJ; Matsushita T; MacCoss M; Hong CI; West CR
J Med Chem; 1982 Nov; 25(11):1322-9. PubMed ID: 7143370
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Harrison SD; O'Dwyer PJ; Trader MW
Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
[TBL] [Abstract][Full Text] [Related]
16. The treatment of intravenously implanted Lewis lung carcinoma with two sustained release forms of 1-beta-D-arabinofuranosylcytosine.
Rahman YE; Patel KR; Cerny EA; Maccoss M
Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1105-12. PubMed ID: 6540691
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
Chandrasekaran B; Capizzi RL; Kute TE; Morgan T; Dimling J
Cancer Res; 1989 Jun; 49(12):3259-66. PubMed ID: 2720678
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
[TBL] [Abstract][Full Text] [Related]
19. Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
Higashigawa M; Hori H; Ohkubo T; Kawasaki H; Yoshizumi T; Sakurai M
Med Oncol Tumor Pharmacother; 1990; 7(4):223-6. PubMed ID: 2283889
[TBL] [Abstract][Full Text] [Related]
20. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
Nagahata T; Shibasaki C; Ishii T; Uchida T; Arakawa M; Kusama K; Ekimoto H; Takahashi K
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
